(August 26, 2019, 11:35 AM EDT) -- ANNAPOLIS, Md.— The Maryland Court of Special Appeals on Aug. 20 affirmed a lower court’s finding that an insurer has no duty to defend against an underlying lawsuit alleging that its insureds participated in a scheme to mass market and distribute “powerful and addictive prescription opioid painkillers” for their financial gain (Rosen-Hoffberg Rehabilitation and Pain Management Associates, P.A., et al. v. Medical Mutual Liability Insurance Society of Maryland, No. 713, September Term, 2018, Md. App., 2019 Md. App. LEXIS 711)....